| Bruker Announces Quarterly Dividend |
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company's common stock. The dividend will be paid on June 27, 2025 to stockholders of record as of June 16, 2025. About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR) Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new app. |
businesswire.com |
2025-05-15 11:00:00 |
Czytaj oryginał (ang.) |
| Bruker and 10x Genomics Reach Global Settlement of Patent Litigation |
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced that Bruker and 10x Genomics have reached a final settlement to resolve their patent disputes and dismiss multiple litigations, with global patent cross license agreements between the two companies. In connection with the settlement, all ongoing lawsuits and administrative proceedings filed by both companies in several countries, including actions pending in the United States, in Germany, and before the Europea. |
businesswire.com |
2025-05-14 11:00:00 |
Czytaj oryginał (ang.) |
| International Markets and Bruker (BRKR): A Deep Dive for Investors |
Explore Bruker's (BRKR) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock. |
zacks.com |
2025-05-13 14:22:05 |
Czytaj oryginał (ang.) |
| Bruker Q1 Earnings & Revenues Top Estimates, Stock Up, Margins Crash |
Bruker delivers better-than-expected earnings and revenues in the first quarter of 2025. |
zacks.com |
2025-05-08 13:10:45 |
Czytaj oryginał (ang.) |
| Bruker Corporation (BRKR) Q1 2025 Earnings Call Transcript |
Bruker Corporation (NASDAQ:BRKR ) Q1 2025 Earnings Conference Call May 7, 2025 8:30 AM ET Company Participants Joe Kostka – Director-Investor Relations Frank Laukien – President and Chief Executive Officer Gerald Herman – Executive Vice President and Chief Financial Officer Conference Call Participants Puneet Souda – Leerink Partners Michael Ryskin – BoA Patrick Donnelly – Citi Tycho Peterson – Jefferies Rachel Vatnsdal – JP Morgan Luke Sergott – Barclays Subbu Nambi – Guggenheim Doug Schenkel – Wolfe Research Operator Good day, and welcome to the Bruker Corporation First Quarter 2025 Earnings Conference Call. All participants will be in listen-only mode. |
seekingalpha.com |
2025-05-07 17:12:16 |
Czytaj oryginał (ang.) |
| Compared to Estimates, Bruker (BRKR) Q1 Earnings: A Look at Key Metrics |
While the top- and bottom-line numbers for Bruker (BRKR) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. |
zacks.com |
2025-05-07 14:36:11 |
Czytaj oryginał (ang.) |
| Bruker (BRKR) Surpasses Q1 Earnings and Revenue Estimates |
Bruker (BRKR) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.53 per share a year ago. |
zacks.com |
2025-05-07 13:30:54 |
Czytaj oryginał (ang.) |
| Earnings Preview: Bruker (BRKR) Q1 Earnings Expected to Decline |
Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
zacks.com |
2025-04-30 15:07:13 |
Czytaj oryginał (ang.) |
| Bruker Spatial Biology Pushes Boundaries in Spatial Biology and Multiomics at AACR 2025 |
CHICAGO--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology and multiomics research at the 2025 American Association for Cancer Research (AACR) General Meeting. These new advancements build upon the innovations announced at AGBT, including launch of CosMx WTX assay for subcellular spatial imaging of the whole transcriptome, the PaintScape™ platform for visualization of 3D genome architecture and chromosomal structur. |
businesswire.com |
2025-04-25 11:00:00 |
Czytaj oryginał (ang.) |
| Bruker to Launch Beacon Discovery™ at AACR 2025, Expanding Access to Live Single-Cell Functional Analysis |
EMERYVILLE, Calif.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced the launch of the Beacon Discovery™ Optofluidic System at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2025. This new Beacon benchtop system offers an accessible entry point into live single-cell functional analysis. Building on Bruker's proprietary Opto-Electrical Positioning (OEP) technology and scalable OptoSelect™ microfluidic chips, Beacon Discovery complements the floor-st. |
businesswire.com |
2025-04-24 11:30:00 |
Czytaj oryginał (ang.) |
| Solis Agrosciences Names Crystal Winkeler Chief Business Officer to Drive Commercial Growth |
Solis Agrosciences, the trusted partner for high-quality AgTech research services, announced that it has hired Crystal Winkeler as Chief Business Officer. |
globenewswire.com |
2025-04-23 10:15:00 |
Czytaj oryginał (ang.) |
| Bruker Introduces nVista 2P Miniature Microscope |
SAN JOSE, Calif.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced the launch of the nVista 2P miniature, two-photon microscope, a groundbreaking addition to the Inscopix product line for functional imaging of freely behaving animals. It leverages advanced two-photon fluorescence microscopy technology to enable high-resolution imaging at greater depths with 3D data reconstruction, providing researchers with unprecedented insights into neuronal activity. Featuring several innov. |
businesswire.com |
2025-04-17 13:00:00 |
Czytaj oryginał (ang.) |
| Bruker Announces Majority Acquisition of RECIPE, a Leading Provider of Mass Spectrometry-based Diagnostic Assay Kits for Therapeutic Drug Monitoring |
MUNICH--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (NASDAQ: BRKR) today announced a majority investment in RECIPE Chemicals + Instruments GmbH, based in Munich, Germany. RECIPE is a leading European provider of vendor-agnostic therapeutic drug monitoring (TDM) and other clinical in vitro diagnostic kits for LC-MS/MS, HPLC, and ICP-MS assays. Financial details of the transaction were not disclosed. RECIPE has over 60 employees and continues to operate under the leadership of Managing Director Dr. Gerno. |
businesswire.com |
2025-04-16 10:00:00 |
Czytaj oryginał (ang.) |
| Bruker Stock May Benefit Following Its Investment in Ridom GmbH |
BRKR announces a new partnership with NGS bioinformatics solution provider Ridom GmbH. |
zacks.com |
2025-04-14 13:27:07 |
Czytaj oryginał (ang.) |
| Bruker Debuts Fourier 80 Multinuclear Benchtop FT-NMR: Stock to Gain? |
BRKR's latest innovation offers 1H NMR and a choice of 15 X-nuclei with just one click. |
zacks.com |
2025-04-11 15:05:35 |
Czytaj oryginał (ang.) |
| Why Is Life Science Focused Bruker Stock Trading Higher On Friday? |
Bruker Corporation BRKR reported preliminary revenue Friday for the first quarter that ended March 31, 2025, of $795 million to $800 million compared to a consensus of $758.85 million. |
benzinga.com |
2025-04-11 14:17:14 |
Czytaj oryginał (ang.) |
| Bruker Announces First Quarter 2025 Preliminary Revenue |
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced preliminary revenue for the first quarter ended March 31, 2025, in a range of $795 million to $800 million, comparing favorably to the Company's earlier outlook and well ahead of consensus. This estimated range implies reported revenue growth of approximately 10% year-over-year, with low-double digit percentage constant exchange rate revenue growth. Bruker estimates non-GAAP organic revenue growth in the first. |
businesswire.com |
2025-04-11 12:00:00 |
Czytaj oryginał (ang.) |
| Bruker Complements Fast, Cost-effective IR Biotyper® Hospital Hygiene Testing and HAI Tracing with NGS Reflex Testing |
VIENNA--(BUSINESS WIRE)---- $BRKR #BRKR--At the ESCMID Global 2025 conference, Bruker´s Microbiology and Infection Diagnostics division is announcing the expansion of its microbiology solutions into Next-Generation Sequencing (NGS) applications, with new, research-use only NGS-based solutions in epidemiology and hospital acquired infection (HAI) tracing. Bruker has entered into a strategic collaboration for NGS bioinformatics applications in microbiology and infectious disease testing with Ridom GmbH, based in. |
businesswire.com |
2025-04-11 10:00:00 |
Czytaj oryginał (ang.) |
| Bruker Announces Groundbreaking 1.3 GHz NMR System, Stock Up |
BRKR's new 1.3 GHz high-resolution NMR system comes with a stable, standard-bore 54 mm superconducting magnet. |
zacks.com |
2025-04-08 14:50:35 |
Czytaj oryginał (ang.) |
| Bruker Announces First-of-a-kind 1.3 GHz High-Resolution NMR System |
ASILOMAR, Calif.--(BUSINESS WIRE)---- $BRKR #BRKR--At the Joint ENC-ISMAR Conference 2025, Bruker Corporation, the leading provider of Nuclear Magnetic Resonance (NMR) spectroscopy solutions, announced the successful development and testing of the world's first high-resolution 1.3 GHz NMR spectrometer with a stable, standard-bore 54 mm superconducting magnet. This first-of-a-kind ultra-high field magnet and spectrometer pushes the boundaries of what is possible in the field of NMR research and opens a new chap. |
businesswire.com |
2025-04-07 11:01:00 |
Czytaj oryginał (ang.) |
| Bruker Launches X4 POSEIDON™ Advanced X-Ray Microscope for Three-Dimensional Microscopy in Industrial and Scientific Applications |
KONTICH, Belgium--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announces the launch of the new X4 POSEIDON™, a high-performance 3D X-ray microscope (XRM) using micro-Computed Tomography (microCT). This innovative benchtop XRM system offers advanced capabilities comparable to larger, floor-standing systems to make high-resolution 3D X-ray microscopy accessible for demanding XRM applications in industrial applications and scientific research. The X4 POSEIDON features a high-end X-ray. |
businesswire.com |
2025-02-27 12:49:00 |
Czytaj oryginał (ang.) |
| Bruker Spatial Biology to Announce Groundbreaking Advances at AGBT 2025 |
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology at the 2025 Advances in Genome Biology and Technology (AGBT) General Meeting. Bruker Spatial Biology will announce the following four innovations that underscore Bruker's leading commitment to advancing spatial biology with pioneering, best-in-class platforms: the first and only Whole Transcriptome Panel (WTX) on the subcellular resolution CosMx Sp. |
businesswire.com |
2025-02-21 10:01:00 |
Czytaj oryginał (ang.) |
| Bruker Appoints Laura Francis to its Board of Directors |
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has appointed Laura Francis to serve on its board as an independent director, effective as of February 18, 2025. Ms. Francis is also expected to join Bruker's Audit Committee as a financial expert after Bruker's annual shareholder meeting at the end of May 2025. Laura Francis is the Chief Executive Officer and a Board Member of SI-BONE, Inc. (Nasdaq: SIBN), a medical device company s. |
businesswire.com |
2025-02-21 10:00:00 |
Czytaj oryginał (ang.) |
| Bruker Announces Quarterly Dividend |
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company's common stock. The dividend will be paid on March 28, 2025 to stockholders of record as of March 17, 2025. About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR) Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new a. |
businesswire.com |
2025-02-21 09:00:00 |
Czytaj oryginał (ang.) |
| Bruker Corporation to Present at Upcoming Investor Conferences |
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today that its senior leadership will present at the following conferences: Citi 2025 Unplugged Medtech and Life Sciences Access Day in New York City Thursday, February 27, 2025, at 2:30 p.m. Eastern Time TD Cowen 45th Annual Health Care Conference in Boston, MA Wednesday, March 5, 2025, at 11:10 a.m. Eastern Time Barclays 27th Annual Global Healthcare Conference in Miami, FL Tuesday, March 11, 2025, at 2:30 p.m. Eas. |
businesswire.com |
2025-02-20 18:01:00 |
Czytaj oryginał (ang.) |
| Bruker Q4 Earnings & Revenues Surpass Estimates, Stock Falls |
Bruker delivers better-than-expected earnings and revenues in the fourth quarter of 2024. |
zacks.com |
2025-02-14 08:46:09 |
Czytaj oryginał (ang.) |
| Bruker Corporation (BRKR) Q4 2024 Earnings Call Transcript |
Bruker Corporation (NASDAQ:BRKR ) Q4 2024 Results Conference Call February 13, 2025 8:30 AM ET Company Participants Joe Kostka - Director, Investor Relations Frank Laukien - President and CEO Gerald Herman - Executive Vice President and CFO Conference Call Participants Puneet Souda - Leerink Partners Elizabeth Speyer - Citigroup Salem Salem - Barclays Brandon Couillard - Wells Fargo Madeline Mollman - Wolfe Research Tycho Peterson - Jefferies Subbu Nambi - Guggenheim Securities Operator Good day, and welcome to the Bruker Corporation Fourth Quarter 2024 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded. |
seekingalpha.com |
2025-02-13 17:22:03 |
Czytaj oryginał (ang.) |
| Bruker (BRKR) Reports Q4 Earnings: What Key Metrics Have to Say |
Although the revenue and EPS for Bruker (BRKR) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. |
zacks.com |
2025-02-13 14:01:10 |
Czytaj oryginał (ang.) |
| Bruker (BRKR) Q4 Earnings and Revenues Surpass Estimates |
Bruker (BRKR) came out with quarterly earnings of $0.76 per share, beating the Zacks Consensus Estimate of $0.75 per share. This compares to earnings of $0.70 per share a year ago. |
zacks.com |
2025-02-13 11:25:18 |
Czytaj oryginał (ang.) |
| Bruker Announces Date and Time of Fourth Quarter 2024 Earnings Release and Webcast |
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2024 financial results before market opening on Thursday, February 13, 2025. The Company will host a conference call and webcast at 8:30 a.m. Eastern Standard Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the “Q4 2024 Earnings Webcast” hyperlink in the “Events & Presentat. |
businesswire.com |
2025-02-07 09:00:00 |
Czytaj oryginał (ang.) |
| Bruker (BRKR) to Report Q4 Results: Wall Street Expects Earnings Growth |
Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
zacks.com |
2025-02-04 13:05:34 |
Czytaj oryginał (ang.) |
| CALID Arm Growth to Support Bruker Shares Amid Macro Issues |
BRKR's NANO Life Science fluorescence microscopy is gaining from product innovation and research demand. |
zacks.com |
2025-01-24 13:06:09 |
Czytaj oryginał (ang.) |
| Bruker Corporation Pivots To Capitalize Its Growing TAM |
Bruker Corporation (NASDAQ: BRKR) is undervalued, trading below its fair value of $74, offering significant upside potential due to its strategic acquisitions and improving book value per share. Recent acquisitions enhance BRKR's capabilities in high-growth markets like Life Sciences, Proteomics, and Spatial Biology, driving sustainable revenue growth and positioning the company for future demand. Despite current weaker EPS and operating margins, BRKR's strong R&D investment and successful integration of acquisitions are expected to boost profitability and growth by FY2025. |
seekingalpha.com |
2025-01-19 19:51:30 |
Czytaj oryginał (ang.) |
| BRKR Stock Up on the Launch of LUMOS II ILIM QCL-Based IR Microscope |
Bruker launches LUMOS II ILIM QCL-based IR microscope for pharma and life science research. |
zacks.com |
2025-01-14 10:46:16 |
Czytaj oryginał (ang.) |
| Bruker Launches Infrared Imaging Microscope for Pharma and Life Science Research |
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced the launch of the LUMOS™ II ILIM, a quantum cascade laser (QCL) based infrared imaging microscope. The new LUMOS II ILIM redefines performance standards, enabling pharma and life science researchers to capture ultrafast IR images of expansive areas with enhanced spatial resolution. The LUMOS II ILIM features a patented coherence reduction method for infrared laser imaging essentially free from artifacts in both. |
businesswire.com |
2025-01-08 09:00:00 |
Czytaj oryginał (ang.) |
| Bruker Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference |
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 43rd annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO, Mark Munch, Executive Vice President & President of Bruker Nano Group, and Gerald Herman, Executive Vice President & CFO will present on behalf of the Company on Monday, January 13th, 2025 at 3:45 PM Pacific Standard Time. A live audio webcast of the presentation will. |
businesswire.com |
2025-01-07 18:05:00 |
Czytaj oryginał (ang.) |
| Bruker Comments on Delaware District Court's Post-Trial Ruling in Case Involving GeoMx Digital Spatial Profiler Products |
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today commented on the ruling of the U.S. District Court for the District of Delaware in the case involving GeoMx® Digital Spatial Profiler products sold by its NanoString business. Yesterday, the Court issued its ruling on the post-trial motions that followed the November 2023 jury verdict in the patent infringement case between NanoString and 10x Genomics. In its ruling, the District Court upheld the jury's damages award of. |
businesswire.com |
2024-12-24 11:28:00 |
Czytaj oryginał (ang.) |
| U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products |
PLEASANTON, Calif. , Dec. 23, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it had secured a permanent injunction in the U.S. District Court for the District of Delaware against the GeoMx products sold by Bruker Corporation (Nasdaq: BRKR), which acquired the product line from NanoString Technologies. |
prnewswire.com |
2024-12-23 18:05:00 |
Czytaj oryginał (ang.) |
| Bruker Adds Another 1.2 GHz NMR System in Switzerland, Stock Climbs |
Bruker announces a 1.2 GHz NMR spectrometer at the Swiss High-field NMR facility. |
zacks.com |
2024-12-23 11:56:07 |
Czytaj oryginał (ang.) |
| Bruker Announces 1.2 GHz NMR Spectrometer at Swiss High-field NMR Facility |
ZÜRICH--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker announces the acceptance of a 1.2 GHz Ascend™ Nuclear Magnetic Resonance (NMR) spectrometer at the Swiss High-field NMR Facility, operated jointly by the University of Basel, ETH Zürich, and the University of Zürich. This state-of-the-art instrument will significantly enhance the research capabilities of several user groups, enabling advanced studies in structural biology and macromolecular analysis. The instrument, located at the University of Zürich, is the sec. |
businesswire.com |
2024-12-20 08:00:00 |
Czytaj oryginał (ang.) |
| Why Is Bruker (BRKR) Up 0.9% Since Last Earnings Report? |
Bruker (BRKR) reported earnings 30 days ago. What's next for the stock? |
zacks.com |
2024-12-05 14:36:08 |
Czytaj oryginał (ang.) |
| Bruker Stock Might Rise From the Launch of Dimension Nexus AFM |
BRKR launches the Dimension Nexus AFM at the 2024 MRS Fall Meeting & Exhibit, expanding its Dimension AFM product line. |
zacks.com |
2024-12-03 12:01:48 |
Czytaj oryginał (ang.) |
| Bruker Introduces Dimension Nexus™ Atomic Force Microscope |
SANTA BARBARA, Calif.--(BUSINESS WIRE)---- $BRKR #BRKR--At the 2024 MRS Fall Meeting & Exhibit, Bruker Corporation (Nasdaq: BRKR) today announced the launch of the Dimension Nexus™ atomic force microscope (AFM). Dimension Nexus is the newest addition to the industry-leading Dimension® AFM product line, which has had more than 4600 systems installed around the world. With the latest-generation NanoScope® 6 controller, this new small-footprint AFM delivers wider access to Bruker's exclusive PeakForce Tapping. |
businesswire.com |
2024-12-02 09:00:00 |
Czytaj oryginał (ang.) |
| New Strong Sell Stocks for November 21st |
BATRA, BAX and BRKR have been added to the Zacks Rank #5 (Strong Sell) List on November 21, 2024. |
zacks.com |
2024-11-21 06:56:12 |
Czytaj oryginał (ang.) |
| New Strong Sell Stocks for November 12th |
BRKR, CMC and CNXC have been added to the Zacks Rank #5 (Strong Sell) List on November 12, 2024. |
zacks.com |
2024-11-12 09:46:07 |
Czytaj oryginał (ang.) |
| Bruker Corporation to Present at Upcoming Investor Conferences |
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today that Gerald Herman, Executive Vice President & CFO will present on behalf of the Company at the following investor conferences: Stifel 2024 Healthcare Conference in New York City Monday, November 18, 2024, at 8:35 a.m. Eastern Time Wolfe Research 2024 Healthcare Conference in New York City Tuesday, November 19, 2024, at 4:10 p.m. Eastern Time Nasdaq 51st Investor Conference in London, UK Tuesday, December 1. |
businesswire.com |
2024-11-12 09:00:00 |
Czytaj oryginał (ang.) |
| BRKR Stock Declines Despite Launching EpicIF Technology for CellScape |
Bruker's new technology, EpicIF, is set to enhance the CellScape Precise Spatial Proteomics platform. |
zacks.com |
2024-11-11 13:31:15 |
Czytaj oryginał (ang.) |
| Bruker Announces EpicIFTM, Revolutionary Fluorescence Signal Removal Technology, Transforming CellScape Spatial Proteomics Platform |
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced a major technological breakthrough in the CellScape™ Precise Spatial Proteomics platform for highly multiplexed immunofluorescence (IF). Launched in 2022, the CellScape platform has advanced the field of spatial proteomics with differentiated quantitative performance enabled by a unique combination of best-in-class resolution and high dynamic range (HDR) imaging. CellScape captures the entire continuum of prote. |
businesswire.com |
2024-11-08 09:00:00 |
Czytaj oryginał (ang.) |
| BRKR Misses on Q3 Earnings, Cuts '24 View, Stock Up in Aftermarket |
Bruker delivers robust revenue growth in the third quarter despite soft general market conditions. |
zacks.com |
2024-11-07 13:50:29 |
Czytaj oryginał (ang.) |
| Bruker Corporation (BRKR) Q3 2024 Earnings Call Transcript |
Bruker Corporation (NASDAQ:BRKR ) Q3 2024 Earnings Conference Call November 5, 2024 8:30 AM ET Company Participants Joe Kostka - Director, Investor Relations Frank Laukien - President and CEO Gerald Herman - Executive Vice President and CFO Conference Call Participants Puneet Souda - Leerink Partners Michael Ryskin - Bank of America Patrick Donnelly - Citi Rachel Vatnsdal - JPMorgan Tycho Peterson - Jefferies Josh Waldman - Cleveland Research Dan Brennan - TD Cowen Brandon Couillard - Wells Fargo Luke Sergott - Barclays Operator Good day. And welcome to the Bruker Corporation Third Quarter 2024 Earnings Call. |
seekingalpha.com |
2024-11-05 13:53:38 |
Czytaj oryginał (ang.) |
| Bruker (BRKR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates |
Although the revenue and EPS for Bruker (BRKR) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. |
zacks.com |
2024-11-05 12:36:21 |
Czytaj oryginał (ang.) |
| Bruker (BRKR) Q3 Earnings and Revenues Lag Estimates |
Bruker (BRKR) came out with quarterly earnings of $0.60 per share, missing the Zacks Consensus Estimate of $0.61 per share. This compares to earnings of $0.74 per share a year ago. |
zacks.com |
2024-11-05 11:25:24 |
Czytaj oryginał (ang.) |
| Bruker Reports Third Quarter 2024 Financial Results |
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced financial results for its third quarter and for the nine months ended September 30, 2024. Frank H. Laukien, Bruker's President and CEO, commented: “Bruker has again posted double-digit year-over-year CER revenue growth, and above-market organic revenue growth, in Q3 and year-to-date. This is a testament to our Project Accelerate transformation, and to our operational excellence processes driving improvements in. |
businesswire.com |
2024-11-05 09:00:00 |
Czytaj oryginał (ang.) |
| Analysts Estimate Bruker (BRKR) to Report a Decline in Earnings: What to Look Out for |
Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
zacks.com |
2024-10-29 13:06:36 |
Czytaj oryginał (ang.) |
| Bruker Announces Date and Time of Third Quarter 2024 Earnings Release and Webcast |
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2024 financial results before market opening on Tuesday, November 5, 2024. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the “Q3 2024 Earnings Webcast” hyperlink in the “Events & Presentations” section. A slide prese. |
businesswire.com |
2024-10-28 18:05:00 |
Czytaj oryginał (ang.) |
| Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics |
DRESDEN, Germany--(BUSINESS WIRE)---- $BRKR #BRKR--At the 23rd Human Proteome Organization World Congress, Bruker Corporation (Nasdaq: BRKR) announces advances in deep, unbiased and high-sensitivity 4D-Proteomics for robust, high- fidelity, large-scale studies - avoiding inherent cross-talk of affinity high-plex technologies. A. Enhanced specificity and proteome coverage using diagonal-PASEF Leveraging scanning quadrupole and trapped ion mobility spectrometry (TIMS), diagonal-PASEF was introduced in 2023 by ke. |
businesswire.com |
2024-10-21 10:00:00 |
Czytaj oryginał (ang.) |